Citations

Showing 10 of 108152 citations.

Abstract P003: Survival after Incident Atrial Fibrillation: A Community-Based Study
McNallan, Sheila M, Weston, Susan A., Roger, Véronique L. , Chamberlain, Alanna M. , Gersh, Bernard J. , Alonso, Álvaro , Chen, Lin Y. , Berardi, Cecilia

Mayo Clinic

Circulation | July 3, 2021 | Volume: 127 | Issue: suppl_12 | Pages: No page available

10.1161/circ.127.suppl_12.ap003 Get It

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice, causes substantial morbidity, and is associated with an excess risk of mortality. However, information on contemporary time trends in survival after AF is lacking. Thus, we aimed to determine whether survival after incident AF has changed over the last decade in a community-based cohort of 3413 individuals with incident AF between 2000 and 2010. Methods: Olmsted County, MN residents 18 years of age and older with a first-ever AF or atrial flutter event between 2000 and 2010 were identified using inpatient and outpatient diagnostic codes and electrocardiograms. Deaths from any cause were ascertained through August 31, 2012 and time trends in survival after AF were examined using Kaplan-Meier curves and Cox proportional hazards regression. Results: Among 3413 individuals with incident AF (52% men, age range 18-104) between 2000 and 2010, 1561 deaths were observed over a median follow-up of 3.4 years. Survival did not differ by year of AF diagnosis (figure). In addition, the proportion of cardiovascular disease-related deaths compared to non-cardiovascular deaths did not differ over time. After adjustment for age, sex, and Charlson comorbidity index, the hazard ratios for all-cause mortality were 1.09 (95% CI 0.97-1.23) for those diagnosed with AF in 2004-2007 vs. 2000-2003 and 1.04 (95% CI 0.90-1.12) for 2008-2010 vs. 2000-2003. Furthermore, the risk of death did not differ by sex after adjustment for age and comorbidity (HR 1.00, 95% CI 0.90-1.11 for men vs. women). Conclusions: In the community, survival after AF has remained constant over the last decade despite substantial changes in the recommendations for treatment of AF. This underscores the importance of identification of prognostic factors and continued surveillance of outcomes in AF, as well as a better understanding of how to optimize the management of AF to improve outcomes in these patients.
Posterior Pericardial Ascending-to-Descending Aortic Bypass
Connolly, Heidi M. , Izhar, Uzi , Warnes, Carole A. , Orszulak, Thomas A., Schaff, Hartzell V. , Dearani, Joseph A.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 104 | Issue: suppl_1 | Pages: No page available

10.1161/circ.104.suppl_1.i-133 Get It

Background Coarctation of the aorta is commonly associated with recoarctation or additional cardiovascular disorders that require intervention. The best surgical approach in such patients is uncertain. Ascending-to-descending aortic bypass graft via the posterior pericardium (CoA bypass) allows simultaneous intracardiac repair or an alternative approach for the patient with complex coarctation. Methods and Results Between 1985 and 2000, 18 patients (13 males and 5 females, mean age 43±13 years) with coarctation of the aorta underwent CoA bypass through median sternotomy. Before operation, average New York Heart Association class was II (range I to IV), and 15 patients (83%) had systemic hypertension. One or more previous cardiovascular operations had been performed in 12 patients (67%); 10 patients had ≥1 prior coarctation repair. Two patients had prior noncoarctation cardiovascular surgery. Concomitant procedures performed in 14 patients (78%) included the following: aortic valve replacement in 9; coronary artery bypass surgery in 3; mitral valve repair in 2; and septal myectomy, mitral valve replacement, aortoplasty, subaortic stenosis resection, ventricular septal defect closure, and ascending aorta replacement in 1 patient each. All patients survived the operation and were alive with patent CoA bypass at a mean follow-up of 45 months. No graft-related complications occurred, and there were no instances of stroke or paraplegia. Systolic blood pressure fell from 159 mm Hg before surgery to 125 mm Hg after surgery. Conclusions CoA bypass via median sternotomy can be performed with low morbidity and mortality. Although management must be individualized, extra-anatomic CoA bypass via the posterior pericardium is an excellent single-stage approach for patients with complex coarctation or recoarctation and concomitant cardiovascular disorders.
Relative Lymphocytopenia and Outcome of Myocardial Infarction.
Roger, Véronique L. , Gabriel, Sherine E., Killian, Jill M. , Reeder, Guy S., Jacobsen, Steven J.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 103 | Issue: suppl_1 | Pages: 1348-1348

10.1161/circ.103.suppl_1.9999-24 Get It

0024 Background: There is evidence for the role of inflammation in the pathogenesis of coronary disease. Relative lymphocytopenia was reported for the diagnosis of myocardial infarction (MI), but little is known about its prognostic value. This study was undertaken to test the hypothesis that relative lymphocytopenia was associated with cardiac events (defined as recurrent MI, congestive heart failure or cardiac death) after MI among Olmsted County residents. Methods: MIs were validated using standard epidemiological criteria using enzymes, chest pain and Minnesota coding of the ECG. The entire community medical record, available via the Rochester Epidemiology Project, was reviewed to determine incident status and ascertain outcomes. Relative lymphocytopenia was defined as percent lymphocytes<20, 3%. Results: Between 1979 and 1994, an incidence cohort of 1653 validated MIs (mean age 67 ± 14, 43% women) was assembled. At the time of index MI, relative lymphocytopenia was present in 51% of the cases. After a mean follow-up of 6.9 ± 5.4 years, 471 pts had experienced recurrent MIs, 849 pts CHF and 602 cardiac deaths occurred. The 5-year event-free survival was 35% for cases with relative lymphocytopenia vs 52% for those without(p<0.001). After adjustment for age and current smoking, relative lymphocytopenia was associated with a 21% increase in the risk of cardiac event (RR 1.21, 95% CI 1.1-1.4; p=0.003). Conclusion: Relative lymphocytopenia is associated with cardiac events after incident MI. These data support the role of inflammation in the outcome of coronary disease.
Attempts at Changing Diet and Exercise to Lower Risk of Coronary Heart Disease and Stroke: Who’s Doing What in the Community?
Brekke, M, Brandel, Catherine L., DeBoer, Stephen W., Thomas, Randal J. , Kottke, Thomas E.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 103 | Issue: suppl_1 | Pages: 1368-1368

10.1161/circ.103.suppl_1.9998-90 Get It

P90 Background and Methods:While only a minority of the population follows a low fat diet and does daily physical activity, it is unclear how much of the population is trying to improve these lifestyle habits. We carried out a telephone survey of 1232 adults, >20 years of age, from Olmsted County, MN to assess their attempts at improving their dietary and exercise habits to lower their risk of developing heart disease and stroke. Results: Fifty-nine percent of respondents reported making attempts to improve exercise habits, 71% reported attempts to improve their eating habits, and 50% reported trying to improve both habits. In all, 80% reported trying to improve exercise and/or dietary habits. Of those trying to change exercise habits, 69% reported at least some physical activity on a daily basis (Pearson correlation = 0.34). Of those attempting to change dietary habits, 31% reported eating at least five servings of fruits and vegetables each day (Pearson correlation = 0.14). After multivariate adjustment, attempts to change diet or exercise were highest in persons trying to lose or maintain weight, and persons who reported having received previous physician advice to change diet and exercise habits. Conclusions: The majority of people in Olmsted County, MN are attempting to change their exercise and dietary habits to reduce their risk of coronary heart disease and stroke. Still, only a minority are meeting recommended dietary and physical activity goals. Since most people are in the action phase of exercise and dietary behavioral change, health promotion messages should include information on how best to improve and maintain these health habits. Furthermore, since report of receiving physician advice is correlated with attempts to change lifestyle habits and since only 44% of the population reports receiving such advice, there is an opportunity for health care providers to impact their patients lives by advising them on how to make improvements in their dietary and exercise habits.
Heart Failure After Myocardial Infarction - A Population-Based Study
Hellermann, Jens, Jacobsen, Steven J. , Yawn, Barbara P. , Weston, Susan A., Redfield, Margaret M. , Rodeheffer, Richard R, Reeder, Guy S., Roger, Véronique L. , Rodeheffer, Richard

Mayo Clinic

Circulation | July 3, 2021 | Volume: 103 | Issue: suppl_1 | Pages: 1359-1359

10.1161/circ.103.suppl_1.9998-46 Get It

P46 While heart failure (HF), an emerging epidemic, complicates myocardial infarction (MI), little is known on the predictors of HF post-MI, in particular the impact of reperfusion therapy. This population-based study was undertaken to examine the association between clinical characteristics and post-MI HF between 1979 and 1994. Hospitalized incident MIs were validated using enzymes, chest pain, and Minnesota coding of the ECG. Framingham criteria were used to ascertain both in- and outpatient HF. Proportional hazard regression was used to identify predictors of CHF. In the study period, 1657 patients (pts.) (mean age 67.2 ± 13.9 years, 43% women) had an incident MI. History of diabetes, hypertension and prior HF was found in 19%, 54% and 11% of pts respectively. After 5 years, 43% of pts had experienced HF. Factors independently associated with HF were (see table). There was a 2% decline per year in occurrence of HF. Adding reperfusion therapy in the model attenuated the association between year and HF (adjusted RR for reperfusion 0.67, 95% CI 0.53, 0.84, p=0.006; adjusted for year 0.99; 95% CI 0.97, 1.01, p=0.37). Thus, while remaining frequent post-MI CHF has declined over time. Reperfusion therapy accounted for most of the effect of year. Table 1.
Genetics of Hypertension, Target-Organ Complications, and Response to Therapy
Boerwinkle, Eric , Turner, Stephen T.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 102 | Issue: suppl_4 | Pages: No page available

10.1161/circ.102.suppl_4.iv-40 Get It

Surgical Patent Foramen Ovale Closure for Prevention of Paradoxical Embolism–Related Cerebrovascular Ischemic Events
Uğurlu, Baran , Danielson, Gordon K., Daly, Richard C. , McGregor, Christopher G.A. , Mullany, Charles J., Puga, Francisco J., Orszulak, Thomas A., Anderson, Betty J., Brown, Robert D. , Dearani, Joseph A. , Schaff, Hartzell V.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 100 | Issue: suppl_2 | Pages: No page available

10.1161/circ.100.suppl_2.ii-171 Get It

Background —The role of surgical closure of patent foramen ovale (PFO) for cerebral infarction (CI) or transient ischemic attack (TIA) resulting from paradoxical embolism is unclear, and its effect on recurrence is unknown. Our objective was to determine the outcome of surgical closure of PFO in patients with a prior ischemic neurological event, define the rate of CI or TIA recurrence after PFO closure, and identify risk factors for these recurrences. Methods and Results —We retrospectively analyzed 91 patients (58 men, 33 women) with ≥1 previous cerebrovascular ischemic events who underwent surgical PFO closure between April 1982 and March 1998. The presence of a PFO with a right-to-left shunt was confirmed with transesophageal echocardiography. Mean age was 44.2±12.2 years. The index event was a CI in 59 and a TIA in 32; a Valsalva-like episode preceded the event in 15 patients. Deep venous thrombosis was documented in 9 patients, and a hypercoagulable state was identified in 10. Surgical closure was performed with extracorporeal circulation by either direct suture (n=82) or patch closure (n=9). Limited incisions were used in 18.7% of patients. There was no operative mortality. Morbidity included transient atrial fibrillation (n=11), pericardial drainage for effusion (n=4), exploration for bleeding (n=3), and superficial wound infection (n=1). Follow-up totaled 176.3 patient-years, and mean follow-up was 2.0 years. No one had a CI, and 8 had a TIA during follow-up, with 1 caused by temporal arteritis. Transesophageal echocardiography demonstrated all closures to be intact in these patients. The overall freedom from TIA recurrence during follow-up was 92.5±3.2% at 1 year and 83.4±6.0% at 4 years. Having multiple neurological events before PFO closure was the only significant risk factor for TIA or CI recurrence after closure by univariate analysis ( P =0.05); the small number of post-PFO closure cerebral ischemic events precluded multivariate analysis. Conclusions —Surgical closure of PFO can be performed with minimal morbidity and mortality. PFO closure may decrease the risk of recurrent stroke or TIA and may avoid lifelong anticoagulation in the young adult if there is no other indication. Recurrent cerebrovascular ischemic events after surgery should prompt further evaluation to identify causes other than paradoxical embolism.
Abstract 266: MicroRNA Profiling Identifies Enrichment for Proteoglycan-Genes in Symptomatic Carotid Plaques
Adhikari, Neeta , Carlson, Marjorie, Loeffler, Darrell , Walek, Dinesha, Daniel, Jerry , Mackey, Aaron J. , Lawson, Mark, Lerman, Amir , Hall, Jennifer L.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | July 3, 2021 | Volume: 32 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.32.suppl_1.a266 Get It

MicroRNAs are a class of small non-coding RNAs that regulate gene expression by binding to discrete sites of genes and inhibiting translation. The objective of this study was to identify microRNAs and downstream enriched targets associated with symptomatic carotid plaques. Carotid plaque samples from patients were defined as symptomatic if they were associated with a prior ischemic stroke or transient ischemic attack, or as asymptomatic if there were no prior ischemic events. Digital microRNA profiling was performed on the NanoString nCounter analysis system (NanoString Technologies, Seattle, WA) on carotid plaques from symptomatic (n=6) and asymptomatic (n=6) patients. We used the BioConductor/R package "edgeR" to perform moderated-ANOVA testing for differences in gene abundance between groups, assuming a negative binomial distribution of gene counts, with Benjamini-Hochberg multiple hypothesis correction to control false discovery rate. Analysis revealed five microRNAs that were significantly up-regulated in the symptomatic cohort (see Table 1) including miR-16, which was confirmed by RTqPCR (p=0.02). Predicted downstream targets of miR-16 were enriched for proteoglycan related genes including hyaluronan synthase 2, perlecan and betaglycan. Additionally, RTqPCR demonstrated up-regulation of CathepsinB transcript in symptomatic patients (n=46-50 per cohort, p=0.02) while CathepsinL and heparanase transcripts were not significantly different. CathepsinL enzyme activity was also not significantly different (n=46-50 per cohort). Taken together, these findings may reveal novel proteoglycan mediated signaling pathways, mediated through miR-16, regulating the progression of carotid plaque formation.
Abstract 7: LPA/PKD-1-HDAC7-FoxO1 Signaling-mediated Endothelial CD36 Transcriptional Repression and Proarteriogenic Reprogramming
Best, Brad, Ramakrishnan, Devi Prasadh, Störz, Peter , Silverstein, Roy L. , Ren, Bin , Walcott, Brian Patrick

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | July 3, 2021 | Volume: 35 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.35.suppl_1.7 Get It

Background: CD36 is a scavenger and antiangiogenic receptor that plays an important role in athero-thrombotic diseases, diabetes and cancer and contributes to obesity. Lysophosphatidic acid (LPA), a bioactive phospholipid signaling mediator, abolishes endothelial cell responses to antiangiogenic proteins containing thrombospondin type 1 homology domains by down-regulating endothelial CD36 transcription via protein kinase PKD-1 signaling. However, the precise mechanism as to how angiogenic signaling is integrated to regulate endothelial specific CD36 transcription remain unknown. Hypothesis: LPA represses CD36 transcription through PKD-1-mediated formation of a nuclear transcriptional complex in endothelial cells. Methods: Microvascular endothelial cells expressing CD36 were used for studying signaling and CD36 transcription by real time RT-qPCR, Western blotting, co-immunoprecipitation or avidin-biotin-conjugated DNA-binding assay; angiogenesis gene array was used for angiogenic gene profiling in response to LPA exposure. Spheroid-based angiogenesis assay, in vivo Matrigel assay and tumor angiogenesis model in CD36 deficiency and wild type mice were established to elucidate mechanisms of angiogenic signaling. Results: CD36 transcriptional repression involved PKD-1 signaling mediated formation of FoxO1-HDAC7 complex in the nucleus of endothelial cells. Unexpectedly, turning off CD36 transcription initiated reprogramming MVECs to express ephrin B2, a critical “molecular signature” involved in angiogenesis and arteriogenesis, and increased phosphorylation of Erk1/2, the MAP kinase important in arterial differentiation. PKD-1 signaling was also shown in tumor endothelium of Lewis lung carcinomas, along with low CD36 expression or CD36 deficiency. Angiogenic branching morphogenesis and in vivo angiogenesis were dependent on PKD-1 signaling. Conclusion: LPA/PKD1-HDAC7-FoxO1 signaling axis regulates endothelial CD36 transcription and mediates silencing of the antiangiogenic switch, resulting in proarteriogenic reprogramming. Targeting this signaling cascade could be a novel approach for cancer, diabetes, athero-thrombotic diseases and obesity.
Abstract 472: Prevalence of Fredrickson-Levy Dyslipidemia Phenotypes at Extreme HDL-C Levels: The Very Large Database of Lipids (VLDL-9B)
Quispe, Renato , Swiger, Kristopher J., Sniderman, Allan D. , Tóth, Peter P. , Jones, Steven R. , Al‐Hijji, Mohammed , Martin, Seth S. , Elshazly, Mohamed Badreldin , Blaha, Michael Joseph , Joshi, Parag H. , Blumenthal, Roger S.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | July 3, 2021 | Volume: 35 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.35.suppl_1.472 Get It

Introduction: Big data techniques offer a novel opportunity to characterize individuals with extreme phenotypes. In this context, we aimed to describe the prevalence of classical Fredrickson-Levy dyslipidemia phenotypes at the extremes of HDL-C levels in a cross-sectional big data study. Methods: We examined 848,801 U.S. adults and children from the Very Large Database of Lipids 1.0 who were referred for lipoprotein testing from 2009 to 2011. We categorized patients into HDL-C percentile categories (<0.1th, 0.1th to 99th to 99.9th, and >99.9th). We examined the prevalence of Fredrickson-Levy dyslipidemia phenotypes (I, IIa, IIb, III, IV and V) within these categories. We identified those who did not meet criteria for any classical dyslipidemia phenotype as the continuum group. Results: Type I and V were mostly present at extremely low HDL-C levels. Type IIa was more prevalent in high vs. low HDL-C levels. Type III was 2-fold more prevalent in extremely low vs. high HDL-C levels. Type IV was the most prevalent classical dyslipidemia phenotype in our population, and was the most frequent at low HDL-C percentiles. About 50% of the extremely low and 90% of the extremely high HDL-C levels were classified into the continuum group. Conclusion: In our cross-sectional big data analysis, there was a significantly higher prevalence of most classical dyslipidemia phenotypes at extremely low HDL-C compared with extremely high HDL-C levels. Only types I and V were more prevalent in extreme groups than general population. To some extent, very low HDL-C levels may be determined by inheritable, highly atherogenic dyslipidemias.